Diagnostics M&A » By The Online Investor Staff, updated Sun., Apr. 28, 10:01 AM
Recent mergers and acquisitions in the Diagnostics M&A category.
Slide #27. Quest Diagnostics — Solstas Lab Partners
Acquirer: |
Quest Diagnostics (NYSE:DGX) |
Acquiree: |
Solstas Lab Partners |
Details: |
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries (Solstas) for a total transaction value of approximately $570 million. Solstas is a portfolio company of Welsh, Carson, Anderson and Stowe, a private-equity firm specializing in information/business services and healthcare businesses. |
Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
Quest Diagnostics SEC Filing Email Alerts Service
Open the DGX Page at The Online Investor »
Company Name: |
Quest Diagnostics, Inc. |
Stock buyback: |
DGX buyback |
Website: |
www.QuestDiagnostics.com |
Sector: |
Diagnostics |
Number of ETFs Holding DGX: |
113 |
Total Market Value Held by ETFs: |
$2.81B |
Total Market Capitalization: |
$15.23B |
% of Market Cap. Held by ETFs: |
18.46% |
|
Open the DGX Page at The Online Investor (in a new window) »
|
April 28, 2024 10:01 AM Eastern
Buy (2.53 out of 4)
6th percentile
|
|